TrialSignal transduction and targeted therapy2026
Liposomal doxorubicin plus nab-paclitaxel with/without chemoradiotherapy in head and neck adenoid cystic carcinoma: single-arm phase II study.
Xinxin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.